United States  

“America's speediest news portal”
One News Page
Regeneron News 
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Koneksa Health to Present Asthma Study at the 2018 American Thoracic Society (ATS) International Conference

Validating Remote FEV1 Monitoring in Moderate Asthmatics to Increase Study Power NEW YORK (PRWEB) May 21, 2018 Koneksa Health, an early-stage company focused on the integration of real-world data..
PRWeb

Retina Group of New York Sponsors Juvenile Diabetes Research Foundation (JDRF) Woodbury, NY Gala

Retina Group of New York (RGONY) is proud to be a corporate Gold Sponsor of the Juvenile Diabetes Research Foundation (JDRF) Gala: One Night in Vegas on Friday, June 1, 2018 at the Crest Hollow Country..
PRWeb

Videos for regeneron

News video: Nasdaq 100 Movers: IDXX, MU

Nasdaq 100 Movers: IDXX, MU 01:06

In early trading on Wednesday, shares of Micron Technology topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.0%. Year to date, Micron Technology registers a..
Source: Market News Video -

News video: Nasdaq 100 Movers: SYMC, REGN

Nasdaq 100 Movers: SYMC, REGN 01:07

In early trading on Friday, shares of Regeneron Pharmaceuticals (REGN) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.5%. Year to date, Regeneron..
Source: Market News Video -

News video: S&P 500 Movers: SYMC, REGN

S&P 500 Movers: SYMC, REGN 01:29

In early trading on Friday, shares of Regeneron Pharmaceuticals (REGN) topped the list of the day's best performing components of the S&P 500 index, trading up 4.3%. Year to date, Regeneron..
Source: Market News Video -

News video: Nasdaq 100 Movers: CHTR, EXPE

Nasdaq 100 Movers: CHTR, EXPE 01:06

In early trading on Friday, shares of Expedia Group topped the list of the day's best performing components of the Nasdaq 100 index, trading up 7.5%. Year to date, Expedia Group has lost about 4.6% of..
Source: Market News Video -

News video: S&P 500 Movers: CHTR, SIVB

S&P 500 Movers: CHTR, SIVB 01:27

In early trading on Friday, shares of SVB Financial Group topped the list of the day's best performing components of the S&P 500 index, trading up 17.1%. Year to date, SVB Financial Group registers a..
Source: Market News Video -

 

Regeneron Unknown: Eylea Future Competition Effects


SeekingAlpha

The Arc Westchester Honors Local Businesses and Employees at 30th Annual Employer Recognition Breakfast

Regeneron received the 2018 Share of Voice Award, the morning’s top honor WESTCHESTER COUNTY, N.Y. (PRWEB) May 17, 2018 The Arc Westchester, the County’s largest agency supporting individuals..
PRWeb

Regeneron and Sanofi's cemiplimab shows positive effect in early-stage lung cancer study


SeekingAlpha

Regeneron & Sanofi's Dupixent successful in late-stage dermatitis study in adolescents


SeekingAlpha

Why The Trade Desk, Noodles & Co., and Regeneron Pharmaceuticals Jumped Today

Find out which of these companies had strong earnings.
Motley Fool

Regeneron: Initiating At These Levels


SeekingAlpha

Why Regeneron Has 30 Percent Upside


SeekingAlpha

3 Reasons Regeneron Stock Could Start Climbing Again

It's been a rough few years, but things are looking up in more ways than one.
Motley Fool

Regeneron: Like Apple In 2016, Hated But Great - And Ready To Roll


SeekingAlpha

Regeneron Pharmaceuticals (REGN) Q1 2018 Results - Earnings Call Transcript


SeekingAlpha

Regeneron and Sanofi's cemiplimab nabs accelerated review in U.S. for type of skin cancer


SeekingAlpha

Regeneron down 6% on underwhelming Q1 results from partner Sanofi


SeekingAlpha

United States: UK Patent Ruling Sharpens Contrast With US Practice - Ropes & Gray LLP

On March 28, 2018, the U.K. Court of Appeal handed down its decision in Regeneron Pharmaceuticals Inc. v. Kymab Ltd. and Novo Nordisk AS, reversing a lower court decision that found two critical..
Mondaq

Liberty All-Star® Growth Fund, Inc. March 2018 Update

Below is the March 2018 Monthly Update for the Liberty All-Star® Growth Fund, Inc. (NYSE: ASG) BOSTON (PRWEB) April 13, 2018 Liberty All-Star Growth Fund, Inc.             Ticker:..
PRWeb

There could be a $35 billion market to treat NASH, a ‘silent disease’ millions are living with — and the competition’s starting to heat up

there could be a $35 billion market to treat nash, a ‘silent disease’ millions are living with — and the competition’s starting to heat up
· *NASH, short for nonalcoholic steatohepatitis, is a type of liver disease in which liver fat builds up in people.* · *It affects an estimated 16 million Americans, but many don't know it until it..
Business Insider

Is Regeneron Pharmaceuticals, Inc. a Buy?

Here's why you should buy Regeneron -- and why you shouldn't.
Motley Fool

Gilead Sciences' Investors Better Watch This Regeneron-Alnylam Deal

The duo is looking to move into nonalcoholic steatohepatitis.
Motley Fool

Alnylam and Regeneron team up in NASH


SeekingAlpha

You Might Like


 Page 1  〉 
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+